(Q35562492)

8 August 2017

1 reference

title

New insights in myeloma-induced osteolysis (English)

1 reference

8 August 2017

New Insights in Myeloma-induced Osteolysis (English)

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

22 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

22 March 2024

1

Sophie Barillé-Nion

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14565645

22 March 2024

author name string

Régis Bataille

2

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14565645

22 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

http://www.tandfonline.com/doi/pdf/10.3109/10428190309178765

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

22 March 2024

1 reference

8 August 2017

volume

44

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

1463-1467

1 reference

8 August 2017

1

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Quantitative histology of myeloma-induced bone changes

22 March 2024

3

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease

22 March 2024

4

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

22 March 2024

5

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

22 March 2024

6

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment

22 March 2024

7

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression

22 March 2024

8

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma

22 March 2024

9

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma

22 March 2024

10

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease

22 March 2024

12

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Breast cancer cells interact with osteoblasts to support osteoclast formation

22 March 2024

13

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation

22 March 2024

14

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells

22 March 2024

15

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease

22 March 2024

16

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand

22 March 2024

17

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease

22 March 2024

19

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

22 March 2024

22

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Anti-myeloma activity of pamidronate in vivo

22 March 2024

23

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity

22 March 2024

24

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord

22 March 2024

25

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

The effect of a single dose of osteoprotegerin in postmenopausal women

22 March 2024

27

1 reference

https://api.crossref.org/works/10.3109/10428190309178765

22 March 2024

Identifiers

10.1080/1042819031000082966

1 reference

8 August 2017

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14565645

22 March 2024

1 reference